RhumbLine Advisers’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16	Closed	-$50K	–	3267
2022 Q1	$50K	Buy	16 +1	+7%	+$3.13K	﹤0.01%	2974
2021 Q4	$93K	Buy	15 +1	+7%	+$6.2K	﹤0.01%	2946
2021 Q3	$134K	Hold	14	–	–	﹤0.01%	2964
2021 Q2	$137K	Buy	+14	New	+$137K	﹤0.01%	2952